Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1991 3
1992 3
1993 2
1994 6
1995 1
1996 2
1997 3
1999 1
2000 3
2001 1
2002 1
2003 4
2004 2
2005 8
2006 8
2007 10
2008 12
2009 29
2010 21
2011 19
2012 26
2013 16
2014 15
2015 20
2016 23
2017 23
2018 14
2019 20
2020 21
2021 36
2022 39
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

345 results
Results by year
Filters applied: . Clear all
Page 1
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, Boumpas DT, Brodin N, Bruce IN, González-Gay MÁ, Jacobsen S, Kerekes G, Marchiori F, Mukhtyar C, Ramos-Casals M, Sattar N, Schreiber K, Sciascia S, Svenungsson E, Szekanecz Z, Tausche AK, Tyndall A, van Halm V, Voskuyl A, Macfarlane GJ, Ward MM, Nurmohamed MT, Tektonidou MG. Drosos GC, et al. Among authors: nurmohamed mt. Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2. Ann Rheum Dis. 2022. PMID: 35110331
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT. Agca R, et al. Among authors: nurmohamed mt. Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3. Ann Rheum Dis. 2017. PMID: 27697765 Review.
Reply.
Rusman T, van der Weijden MAC, Nurmohamed MT, van der Bijl CMA, van der Laken CJ, Bet PM, Landewé RBM, de Winter JJH, Boden BJH, van der Horst-Bruinsma IE. Rusman T, et al. Among authors: nurmohamed mt. Arthritis Rheumatol. 2021 Dec;73(12):2352-2353. doi: 10.1002/art.41908. Epub 2021 Oct 25. Arthritis Rheumatol. 2021. PMID: 34180159 No abstract available.
Cardiovascular effects of approved drugs for rheumatoid arthritis.
Atzeni F, Rodríguez-Carrio J, Popa CD, Nurmohamed MT, Szűcs G, Szekanecz Z. Atzeni F, et al. Among authors: nurmohamed mt. Nat Rev Rheumatol. 2021 May;17(5):270-290. doi: 10.1038/s41584-021-00593-3. Epub 2021 Apr 8. Nat Rev Rheumatol. 2021. PMID: 33833437 Review.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes IB, Sattar N, Stamm TA, Takeuchi T, Trauner M, van der Heijde D, Voshaar M, Winthrop KL, Ravelli A, Betteridge N, Burmester GR, Bijlsma JW, Bykerk V, Caporali R, Choy EH, Codreanu C, Combe B, Crow MK, de Wit M, Emery P, Fleischmann RM, Gabay C, Hetland ML, Hyrich KL, Iagnocco A, Isaacs JD, Kremer JM, Mariette X, Merkel PA, Mysler EF, Nash P, Nurmohamed MT, Pavelka K, Poor G, Rubbert-Roth A, Schulze-Koops H, Strangfeld A, Tanaka Y, Smolen JS. Aletaha D, et al. Among authors: nurmohamed mt. Ann Rheum Dis. 2022 Aug 11:annrheumdis-2022-222784. doi: 10.1136/ard-2022-222784. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35953263
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.
Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT. Hansildaar R, et al. Among authors: nurmohamed mt. Lancet Rheumatol. 2021 Jan;3(1):e58-e70. doi: 10.1016/S2665-9913(20)30221-6. Epub 2020 Sep 1. Lancet Rheumatol. 2021. PMID: 32904897 Free PMC article. Review.
Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
Caporali R, Allanore Y, Alten R, Combe B, Durez P, Iannone F, Nurmohamed MT, Lee SJ, Kwon TS, Choi JS, Park G, Yoo DH. Caporali R, et al. Among authors: nurmohamed mt. Expert Rev Clin Immunol. 2021 Jan;17(1):85-99. doi: 10.1080/1744666X.2020.1858803. Epub 2020 Dec 28. Expert Rev Clin Immunol. 2021. PMID: 33305638
Editorial: Comorbidity Burden in Rheumatic Diseases.
Nikiphorou E, Nurmohamed MT, Szekanecz Z. Nikiphorou E, et al. Among authors: nurmohamed mt. Front Med (Lausanne). 2018 Jul 3;5:197. doi: 10.3389/fmed.2018.00197. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30018957 Free PMC article. No abstract available.
Cardiovascular comorbidity in rheumatic diseases.
Nurmohamed MT, Heslinga M, Kitas GD. Nurmohamed MT, et al. Nat Rev Rheumatol. 2015 Dec;11(12):693-704. doi: 10.1038/nrrheum.2015.112. Epub 2015 Aug 18. Nat Rev Rheumatol. 2015. PMID: 26282082 Review.
345 results